Kitsa provides an integrated platform utilizing agentic AI to streamline clinical trial operations. The platform automates the generation of regulatory documents, ensuring guideline adherence and consistency across submissions. It also uses multi-dimensional AI scoring to rapidly match protocols with high-scoring research sites and identifies eligible patient cohorts via EHR data analysis.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical trials often face enrollment delays, with a significant percentage failing to meet enrollment timelines, leading to costly delays in bringing new therapies to market. Many patients and physicians, especially those in rural or community-based settings, lack access to clinical trial opportunities.
Solution
Kitsa provides a HIPAA-compliant platform that streamlines patient pre-screening and recruitment for clinical trials, connecting sponsors with a broader network of providers and patients. The platform integrates with electronic health records (EHRs) to automate the identification of patient cohorts suitable for specific trials, reducing the workload on clinical staff. Kitsa facilitates patient referrals and enables providers to participate in clinical trials as sub-investigators or principal investigators. For sponsors, Kitsa offers tools to conduct protocol feasibility analyses, identify suitable sites, and monitor enrollment progress in real-time.
Target Audience
The primary target audience includes pharmaceutical sponsors, clinical research sites, rural hospitals, community centers, physician practices, and patient registries seeking to improve clinical trial enrollment and access.
Features
- EHR integration for automated patient cohort identification
- AI-driven patient matching to relevant clinical trials
- Streamlined patient referral process
- Real-time monitoring of recruitment progress for sponsors
- Protocol feasibility analysis tools
- Network of providers and patients to broaden trial access
- HIPAA-compliant platform ensuring data privacy and security